Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy

Chest

Volumn 128, Issue 5, 2005, Pages 3269-3275

  Furukawa, Kinya ^a   Kato, Harubumi ^a   Konaka, Chimori ^a   Okunaka, Tetsuija ^b   Usuda, Jituo ^a   Ebihara, Yoshiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA SANNO HOSPITAL   (Japan)

Author keywords

Early stage lung cancer; Occult lung cancer; Photodynamic therapy; Porfimer sodium

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS; CANCER INVASION; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; EARLY CANCER; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LASER; LUNG CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR CELL;

EID: 28144455507     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3269     Document Type: Article

References (26)

1. Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982; 81:269-277
2. Kato H, Konaka C, Kawate N, et al. Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy. Chest 1986; 90:768-770
3. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc 1987; 62:8-14
4. Edell ES, Cortese DA. Bronchoscopic localization and treatment of occult lung cancer, Chest 1989; 96:919-921
5. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993; 11:1852-1187
6. Kato H. Photodynamic therapy for lung cancer: a review of 19 years' experience. J Photochem Photobiol 1998; B42:96-99
7. Kato H, Furukawa K, Sato M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003; 42:103-111
8. Niedre M, Patterson MS, Wilson BC. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem Photobiol 2002; 75:382-391
9. General rules for clinical and pathological records of lung cancer. 4th ed. In: Japan Lung Cancer Society, eds. Tokyo, Japan: Kanehara and Company, 1995; 123-133
10. Niiya H. Toxicity grading criteria of the Japan Clinical Oncology Group. Int J Clin Oncol 1997; 32:61-65
11. Konaka C, Miura H, Ikeda N, et al. The characteristics of early bronchogenic carcinoma evaluated by cytomorphological features. Lung Cancer 2002; 38:267-271
12. Dougherty TJ, Lawrence G, Kaufman JH, et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1978; 62:231-237
13. Nagamoto N, Saito Y, Ohta S, et al. Relationship of lymph node metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer. Am J Surg Pathol 1989; 13:1009-1013
14. Nagamoto N, Saito Y, Sato M, et al. Clinicopathological analysis of 19 cases of isolated carcinoma in situ of the bronchus. Am J Surg Pathol 1993; 17:1234-1243
15. Nakamura H, Kawasaki N, Hagiwara M, et al. Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung. Cancer 2001; 91:1142-1147
16. Akaogi E, Ogawa I, Mitsui K, et al. Endoscopic criteria of early squamous cell carcinoma of the bronchus. Cancer 1994; 74:3113-3117
17. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
18. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102:1319-1322
19. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72:595-602
20. Kurimoto N, Murayama M, Yoshioka S, et al. Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion. Chest 1999; 115:1500-1506
21. Miyazu Y, Miyazawa T, Kurimoto N, et al. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 2002; 165:832-837
22. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998; 113:696-702
23. Ikeda N, Hiyoshi T, Kakihana M, et al. Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancer. Lung Cancer 2003; 41:303-309
24. Sutedja TG, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest 2001; 120:1327-1332
25. Sutedja TG, Venmans BJ, Smit EF, et al. Fluorescence bronchoscopy for early detection of lung cancer: a clinical perspective. Lung Cancer 2001; 34:157-168
26. Furukawa K, Ikeda N, Miura T, et al. Is autofluorescence bronchoscopy needed to diagnose early bronchogenic carcinoma? J Bronchol 2003; 10:64-69